Nafata 360 Pharma International Private Limited - Company Profile

It is a pharma private limited company based in Kollam, Kerala, India, established in 2018.
2018 Kollam, Kerala, India Struck Off
Last Updated:
Access Report
About Nafata 360 Pharma International Private Limited

Nafata 360 Pharma International Private Limited, a struck off private limited company, was established on 23 January 2018 in Kollam, Kerala, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U51909KL2018PTC051891. Registered under ROC Roc Ernakulam. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.

Its leadership includes Nazarudeen Ebrahimkutty (Director), Fathahudeen (Director). It holds no open charges and ₹1.00 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Shop No. 19/86, Al Jood Kottiyam Po, Kollam, Kerala, 691571.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U51909KL2018PTC051891

  • Registration Number

    051891

  • Incorporation Date

    23 January 2018

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹1.00 M

  • ROC Code

    Roc Ernakulam

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 1.00 M
  • Company Age 8 Year, 1 Month
  • Last Filing with ROC 31 Mar 2024
  • Satisfied Charges ₹ 1.00 M
  • Revenue Growth **** -36.77%
  • Profit Growth **** -299.23%
  • Ebitda **** 157.08%
  • Net Worth -3395.08%
  • Total Assets -81.65%
Company report

Nafata 360 Pharma International Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Nafata 360 Pharma International Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Nafata 360 Pharma International Private Limited?
Current Directors
Name Designation Appointment Date Status
Nazarudeen Ebrahimkutty Director 23 Jan 2018 Current
Fathahudeen Director 23 Jan 2018 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Nafata 360 Pharma International.

Nafata 360 Pharma International Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 36.77% decrease. The company also saw a substantial fall in profitability, with a 299.23% decrease in profit. The company's net worth observed a substantial decline by a decrease of 3395.08%.

Nafata 360 Pharma International revenue growth over time
Nafata 360 Pharma International profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -36.77%
*******
*******
*******
*******
Revenue from Operations
*******
 -36.77%
*******
*******
*******
*******
Total Assets
*******
 -81.65%
*******
*******
*******
*******
Profit or Loss
*******
 -299.23%
*******
*******
*******
*******
Net Worth
*******
 -3395.08%
*******
*******
*******
*******
EBITDA
*******
 157.08%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Nafata 360 Pharma International?

Unlock access to Nafata 360 Pharma International's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹0

Satisfied Charges

₹1,000,000.00

Charges Breakdown by Lending Institutions
  • Canara Bank : 0.10 Cr
Latest Charge Details
Date Lender Amount Status
20 Jul 2018 Canara Bank ₹1.00 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Nafata 360 Pharma International?

Unlock and access historical data on people associated with Nafata 360 Pharma International, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Nafata 360 Pharma International, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nafata 360 Pharma International's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Nafata 360 Pharma International
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Nafata 360 Pharma International Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.

  • Balance Sheet

    Nafata 360 Pharma International Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ernakulam. was recorded as a recent event.

  • Charges

    A charge registered on 20 Jul 2018 via Charge ID 100217405 with Canara Bank was fully satisfied on 03 Dec 2019. was recorded as a recent event.

  • Charges

    A charge with Canara Bank amounted to Rs. 1.00 M with Charge ID 100217405 was registered on 20 Jul 2018. was recorded as a recent event.

  • Director Appointment

    The activity Nazarudeen Ebrahimkutty was appointed as a Director was appointed as a Director on 23 Jan 2018 & has been associated with this company since 8 years 1 month . was completed.

  • Director Appointment

    Fathahudeen was appointed as a Director was appointed as a Director on 23 Jan 2018 & has been associated with this company since 8 years 1 month . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Nafata 360 Pharma International Private Limited?

The CIN of Nafata 360 Pharma International Private Limited is U51909KL2018PTC051891.

Where is Nafata 360 Pharma International Private Limited headquartered?

Nafata 360 Pharma International Private Limited is headquartered at Shop No. 19/86, Al Jood Kottiyam Po, Kollam, Kerala, 691571.

When was Nafata 360 Pharma International Private Limited incorporated?

Nafata 360 Pharma International Private Limited was incorporated on 23 January 2018.

Who are the current directors of Nafata 360 Pharma International Private Limited?

The current directors of Nafata 360 Pharma International Private Limited are

What is the primary industry of Nafata 360 Pharma International Private Limited?

The primary industry of Nafata 360 Pharma International Private Limited is Pharma.

Is Nafata 360 Pharma International Private Limited a listed company?

Nafata 360 Pharma International Private Limited is unlisted.

What is the capital structure of Nafata 360 Pharma International Private Limited?

The authorized capital of Nafata 360 Pharma International Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available